Moreover, recent studies also showed that positive TSG101 expression was associated with the clinical, pathological, and biological behaviors and with poor prognosis in breast cancer and hepatocellular carcinoma [18, 19]. This evidence concerns the gene TSG101 and breast carcinoma.